Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638599-18-001326
Filing Date
2018-12-06
Accepted
2018-12-06 06:01:19
Documents
1
Period of Report
2018-12-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc4_5816.html 4  
1 PRIMARY DOCUMENT doc4_5816.xml 4 6644
  Complete submission text file 0001638599-18-001326.txt   8064
Mailing Address 420 CHIPETA WAY SALT LAKE CITY UT 84108
Business Address
BROWN MORGAN R (Reporting) CIK: 0001266062 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36357 | Film No.: 181218605

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Issuer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations